TY - JOUR
T1 - Involvement of a serine protease in the synthesis of platelet-activating factor by endothelial cells stimulated by tumor necrosis factor-α or interleukin-1α
AU - Bussolino, Federico
AU - Arese, Marco
AU - Silvestro, Lugi
AU - Soldi, Raffaella
AU - Benfenati, Emilio
AU - Sanavio, Fiorella
AU - Aglietta, Massimo
AU - Bosia, Amalia
AU - Camussi, Giovanni
PY - 1994/12
Y1 - 1994/12
N2 - It has been shown that production of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by endothelial cells (EC) stimulated with tumor necrosis factor (TNF)-α and interleukin (IL)-1α requires the synthesis of new proteins and is regulated by anti-proteinases. Here, we demonstrate that TNF-α and IL-1α induce the expression by EC of a 34-kDa diisopropyl fluorophosphate-binding protein immunoprecipitated by an antihuman elastase antibody. This protein is released in the medium and cleaves the chromogenic substrate N-methoxysuccinyl- Ala-Ala-Pro-Val p-anilide, which is specific for elastase. The generation of this elastase-like protein seems to be important for the synthesis of PAF induced by TNF-α and IL-1α, as suggested by the following observations: (a) it precedes the synthesis of PAF; (b) the inhibitors of serine protease and anti-human elastase antibody prevent the synthesis of PAF and the activation of 1-O-alkyl-2-lyso-glycerophosphocholine acetyl-CoA: acetyltransferase, which is a key enzyme of the PAF remodelling pathway; (c) elastase, at concentrations similar to that detectable in the medium of cytokine-activated EC, elicits a rapid synthesis of PAF by EC. High-performance liquid chromatography-tandem mass spectrometric analysis of bioactive PAF demonstrates that the molecular species produced after stimulation of EC with TNF-α, IL-1α or elastase are similar, with a predominant synthesis of the alkyl species. These results indicate that TNF-α and IL-1α stimulate the production of a serine protease which is critical in the activation of enzymes involved in PAF synthesis, suggesting the potential involvement of this mechanism in the regulation of EC functions.
AB - It has been shown that production of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by endothelial cells (EC) stimulated with tumor necrosis factor (TNF)-α and interleukin (IL)-1α requires the synthesis of new proteins and is regulated by anti-proteinases. Here, we demonstrate that TNF-α and IL-1α induce the expression by EC of a 34-kDa diisopropyl fluorophosphate-binding protein immunoprecipitated by an antihuman elastase antibody. This protein is released in the medium and cleaves the chromogenic substrate N-methoxysuccinyl- Ala-Ala-Pro-Val p-anilide, which is specific for elastase. The generation of this elastase-like protein seems to be important for the synthesis of PAF induced by TNF-α and IL-1α, as suggested by the following observations: (a) it precedes the synthesis of PAF; (b) the inhibitors of serine protease and anti-human elastase antibody prevent the synthesis of PAF and the activation of 1-O-alkyl-2-lyso-glycerophosphocholine acetyl-CoA: acetyltransferase, which is a key enzyme of the PAF remodelling pathway; (c) elastase, at concentrations similar to that detectable in the medium of cytokine-activated EC, elicits a rapid synthesis of PAF by EC. High-performance liquid chromatography-tandem mass spectrometric analysis of bioactive PAF demonstrates that the molecular species produced after stimulation of EC with TNF-α, IL-1α or elastase are similar, with a predominant synthesis of the alkyl species. These results indicate that TNF-α and IL-1α stimulate the production of a serine protease which is critical in the activation of enzymes involved in PAF synthesis, suggesting the potential involvement of this mechanism in the regulation of EC functions.
KW - Elastase
KW - Endothelial cells
KW - Interleukin-1
KW - Platelet-activating factor
KW - Tumor necrosis factor
UR - http://www.scopus.com/inward/record.url?scp=0028586814&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028586814&partnerID=8YFLogxK
U2 - 10.1002/eji.1830241233
DO - 10.1002/eji.1830241233
M3 - Article
C2 - 7805742
AN - SCOPUS:0028586814
SN - 0014-2980
VL - 24
SP - 3131
EP - 3139
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 12
ER -